Mounjaro, Lilly and European Union

EU drugs regulator backs Mounjaro's sleep apnea use without fresh approval for Lilly
The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it has benefit in treating a sleep disorder without approving it specifically for the disease,
Eli Lilly’s Mounjaro Won’t Have Separate Sleep Apnea Label in EU
Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with regulators saying Friday that use of the drug is already covered in its approval as a weight-loss medicine.
Lilly's Mounjaro does not need separate indication for sleep apnea, EMA panel determines
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has determined that Eli Lilly's (NYSE:LLY) weight-loss drug Mounjaro (tirzepatide) does not need a separate indication for the treatment of obstructive sleep apnea (OSA).
EMA says Lilly's weight-loss drug does not need separate approval for sleep apnea
The European Medicines Agency said on Friday Eli Lilly's weight-loss drug Mounjaro does not need a separate approval for the treatment of a sleep disorder called obstructive sleep apnea (OSA). The hea
Eli Lilly to test weight loss drug Zepbound to treat addiction
Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?
What is Mounjaro? The Ozempic-style weight-loss drug being rolled out on the NHS
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
WTVD1d
Weight-loss drugs like Ozempic & Mounjaro could help curb addiction, studies suggest
The active ingredients in Ozempic, Mounjaro, and similar medications mimic hormones that help regulate blood sugar and ...
Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...
STAT1d
Pharmalittle: We’re reading about Editas layoffs, House Republicans probing CVS, and more
Editas plans to lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell ...
Reuters on MSN1d
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
Sweeping deportations pledged by President-elect Donald Trump could pose an economic shock for the restaurant industry in ...
Daily Record on MSN9d
NHS Mounjaro warning as most will not be able to access new weightloss drug
Nice has endorsed Mounjaro, also known as tirzepatide and produced by Eli Lilly, for individuals with a body mass index ...
What is Mounjaro? The new NHS weight loss jab with a 12-year wait
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...
Weight-loss drug Mounjaro will help 'so many' people, say users
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
pharmaphorum9d
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
What is Mounjaro and how does the weight-loss jab work?
Mounjaro is the brand name for a drug called tirzepatide, which is a glucagon-like peptide-1 (GLP-1) that helps to lower ...
Parade on MSN2d
Whoopi Goldberg Defends Ozempic Use After RFK Jr.'s Strong Message About Weight Loss Drug
Whoopi Goldberg strongly disagreed with Robert F. Kennedy Jr.'s recent criticism of weight loss drugs like Ozempic and ...